Edit
List Biotherapeutics
https://listlabs.com/microbiome-manufacturing-facility/Last activity: 11.11.2021
List Labs is on track to provide fully integrated end-to-end service for innovators of microbiome therapeutics (LBPs) with a new 130,000 sq ft, state-of-the-art, commercial CDMO facility by Q4, 2024. List Labs is directing the design and construction of the expansion via the establishment of new provisional sister company, List Biotherapeutics.
Location: United States, California, Campbell
Employees: 11-50
Total raised: $48.4M
Founded date: 1978
Investors 2
| Date | Name | Website |
| - | SV Investm... | svinvest.c... |
| - | we venture... | en.weventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.04.2022 | - | $48.4M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 11.11.2021 | List Biotherapeutics Establishes New Microbiome Manufacturin... | List Biotherapeutics, Inc. (List Bio), whose parent company is South Korea-based Genome & Compan... | marketscre... |
| 27.10.2020 | List Labs Launches New, Feature-Rich Website | CAMPBELL, Calif., Oct. 27, 2020 /PRNewswire/ -- List Labs is proud to announce the launch of its n... | prnewswire... |